康华医疗2024中报

( 前稱廣東康華醫療股份有限公司 )(Formerly known as Guangdong Kanghua Healthcare Co., Ltd.)( 於中華人民共和國註冊成立的股份有限公司 )(A joint stock company incorporated in the People's Republic of China with limited liability) 股份代號 Stock Code:3689* 僅供識別 For identification purposes only 2024I N T E R I MR E P O R T中 報 Contents目錄 2Corporate Information公司資料4Financial Highlights財務概覽6Management Discussion and Analysis管理層討論及分析44Corporate Governance Highlights企業管治概覽47Other Information其他資料56Report on Review of Interim Condensed ConsolidatedFinancial Information中期簡明綜合財務資料審閱報告58Interim Condensed Consolidated Statement of Profit orLoss and Other Comprehensive Income中期簡明綜合損益及其他全面收益表59Interim Condensed Consolidated Statement of Financial Position中期簡明綜合財務狀況表61Interim Condensed Consolidated Statement of Changes in Equity中期簡明綜合權益變動表62Interim Condensed Consolidated Statement of Cash Flows中期簡明綜合現金流量表63Notes to Interim Condensed Consolidated Financial Information中期簡明綜合財務資料附註92Definitions釋義 Corporate Information公司資料 董事會 BOARD OF DIRECTORS 執行董事 Executive Directors 王君揚先生（主席）陳旺枝先生（行政總裁）王偉雄先生（副主席）王愛勤女士 Mr. Wang Junyang(Chairman)Mr. Chen Wangzhi(Chief Executive Officer)Mr. Wong Wai Hung(Vice Chairman)Ms. Wang Aiqin 非執行董事 Non-executive Director 呂玉波先生 Mr. Lv Yubo 獨立非執行董事 Independent Non-executive Directors 楊銘澧先生陳可冀醫生陳星能先生 Mr. Yeung Ming LaiDr. Chen KejiMr. Chan Sing Nun 審核委員會 Audit Committee 陳星能先生（主席）陳可冀醫生楊銘澧先生 Mr. Chan Sing Nun(Chairman)Dr. Chen KejiMr. Yeung Ming Lai 薪酬委員會 Remuneration Committee 陳星能先生（主席）王愛勤女士楊銘澧先生 Mr. Chan Sing Nun(Chairman)Ms. Wang AiqinMr. Yeung Ming Lai 提名委員會 Nomination Committee 王君揚先生（主席）陳可冀醫生楊銘澧先生 Mr. Wang Junyang(Chairman)Dr. Chen KejiMr. Yeung Ming Lai 監事會 SUPERVISORY COMMITTEE 陳少明先生（主席）王少鋒先生岳春陽先生 Mr. Chen Shaoming(Chairman)Mr. Wang ShaofengMr. Yue Chunyang 聯席公司秘書 JOINT COMPANY SECRETARIES 黃偉恒先生周慶齡女士 Mr. Wong Wai Hang RickyMs. Chau Hing Ling 董事會秘書 SECRETARY TO THE BOARD 黃偉恒先生 Mr. Wong Wai Hang Ricky Corporate Information公司資料 授權代表 AUTHORISED REPRESENTATIVES 王偉雄先生黃偉恒先生 Mr. Wong Wai HungMr. Wong Wai Hang Ricky 核數師 AUDITOR 天職香港會計師事務所有限公司執業會計師註冊公眾利益實體核數師 Baker Tilly Hong Kong LimitedCertified Public AccountantsRegistered Public Interest Entity Auditor 香港法律顧問 LEGAL ADVISERS AS TO HONG KONG LAWS 偉凱律師事務所 White & Case 中國法律顧問 LEGAL ADVISERS AS TO PRC LAWS Commerce & Finance Law Offices 註冊辦事處 REGISTERED OFFICE 中國廣東省東莞市南城街道東莞康華醫院門診一區3樓 3/F, Outpatient Zone OneDongguan Kanghua HospitalNancheng Street RoadDongguanGuangdong ProvincePRC HEAD OFFICE IN THE PRC 中國總部 中國廣東省東莞市東莞大道1000號 1000 Dongguan AvenueDongguanGuangdong ProvincePRC 香港主要營業地點 PRINCIPAL PLACE OF BUSINESS IN HONG KONG 香港新界葵芳興芳路223號新都會廣場第二座3207室 Unit 3207, Metroplaza Tower 2223 Hing Fong RoadKwai Fong, New TerritoriesHong Kong H股證券登記處 H SHARE REGISTRAR 香港中央證券登記有限公司香港灣仔皇后大道東183號合和中心17樓1712–1716號舖 Computershare Hong Kong Investor Services LimitedShops 1712–1716, 17th FloorHopewell Centre183 Queen’s Road EastWanchaiHong Kong 股份代號 STOCK CODE 3689 3689 公司網站http://www.kanghuagp.com COMPANY’S WEBSITE http://www.kanghuagp.com Financial Highlights財務概覽 KEY FINANCIAL PERFORMANCE主要財務表現 經 調 整EBITDA為 除 銀 行 及 其 他 利 息 收 入、利 息 開 支、稅 項、折 舊 及 攤 銷、按 公 平 值計入損益的金融資產公平值收益（虧損）及按公平值計入損益的金融資產投資收入及匯兌收益（虧損）淨額前的盈利。 #Adjusted EBITDA is earnings before accounting for bank and other interest income,interest expenses, taxes, depreciation and amortisation, fair value gain (loss) onfinancial assets at fair value through profit or loss and investment income fromfinancial assets at fair value through profit or loss and net exchange gain (loss). Management Discussion and Analysis管理層討論及分析 業務回顧和展望 BUSINESS REVIEW AND OUTLOOK 截至二零二四年六月三十日止六個月的業務概覽 Business Overview for the six months ended 30 June 2024 In the first half of 2024, the overall economic development in China remainedsteady, with the gross domestic product (GDP) reaching RMB61.7 trillion,representing a year-on-year increase of 5.0% at constant price, according todata from the National Bureau of Statistics. However, the healthcare industryis still in a critical period of transition and the overall recovery of the healthcareand medical service industry is relatively weak. In 2024 so far, the healthcareindustry has continued to evolve rapidly, as the comprehensive reforms in thehealthcare system reshape the market and industry participants, the Chinesegovernment is implementing policies aimed at improving healthcare accessibilityand affordability, including implementing laws requiring hospitals and healthcareproviders to improve price transparency, emphasizing value-based care,reviewing and adjusting payment rates for different Diagnosis-Related Group(DRG) payment groups, expanding insurance coverage and promoting public-private partnerships. 國家統計局數據顯示，二零二四年上半年，中國經濟發展整體保持平穩，國內生產總值(GDP)達到人民幣61.7萬億元，按固定價格計算，同比增長5.0%。然而，醫療保健行業仍處於轉型的關鍵時期，醫療保健及醫療服務行業的整體復甦勢頭相對較弱。二零二四年至今，醫療保健行業持續快速發展，隨著醫療體系的全面改革重塑了市場及行業參與者，中 國 政 府 正 在 實 施 旨 在 提 高 醫 療 保 健 可 及性及可負擔性的政策，包括實施規定醫院及醫療保健提供者提高價格透明度的法律、強調以價值為基礎的醫療服務、檢討